The Domestication is a routine legal reincorporation with no operational or financial impact. Monitor the shareholder vote on November 10, 2026, and the subsequent effective date around March 1, 2027 for any potential index or institutional ownership changes.
Price Chart
Executive Summary
Genpact filed Amendment No. 2 to its S-4 registration statement to seek shareholder approval to redomicile from Bermuda to Delaware (the 'Domestication'). The special meeting is scheduled for November 10, 2026, with an expected effective date of March 1, 2027. The filing is a routine corporate governance change with no financial impact on operations or earnings.
Key Facts
- Shareholders to vote on domestication from Bermuda to Delaware at a special meeting on November 10, 2026.
- Domestication expected to be effective on or around March 1, 2027, subject to shareholder and Board approval.
- No change in business, operations, fiscal year, management, or Board of Directors.
- Common shares will convert 1:1 into common stock of the Delaware entity; ticker symbol 'G' unchanged.
- No appraisal rights available for shareholders in connection with the Domestication.
- Closing price of common shares as of October 2, 2026 was $33.29.
- 167,227,006 common shares outstanding as of September 30, 2026.
Financial Impact
No financial figures reported; the Domestication is a legal reincorporation with no change to assets, liabilities, or operations.
Risk Factors
- Shareholders may not approve the Domestication, leaving the company incorporated in Bermuda.
- Potential changes to effective tax rate post-Domestication as Genpact Delaware becomes subject to U.S. corporate tax.
- Transaction costs incurred regardless of whether the Domestication is completed.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-4/A Filing (Primary) | 0001140361-26-038570 |
| Document: ny20078357x4_ex23-3.htm | 0001140361-26-038570 |
| Document: 0001140361-26-038570-index-headers.html | 0001140361-26-038570 |
| Document: 0001140361-26-038570-index.html | 0001140361-26-038570 |
| Document: 0001140361-26-038570.txt | 0001140361-26-038570 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | Press Release | $37.26 | awaiting T+20 | — | $40.48 (+8.64%) |
Oct 8, 2026 19d ago | EFFECT | $34.67 | awaiting T+20 | — | $40.48 (+16.76%) |
Oct 5, 2026 21d ago | S-4/A | $33.52 | awaiting T+20 | — | $40.48 (+20.76%) |
Aug 20, 2026 9w ago | Insider Cluster | $37.14 $34.08 | ▼ −8.24% | ▼ −9.26% | $40.48 (+8.99%) |
Aug 18, 2026 9w ago | Insider Cluster | $36.20 $34.95 | ▼ −3.46% | ▼ −2.62% | $40.48 (+11.81%) |
Aug 14, 2026 10w ago | Insider Cluster | $33.70 $35.86 | ▲ +6.41% | ▲ +8.39% | $40.48 (+20.12%) |
Mar 11, 2026 32w ago | DEFA14A | $38.65 $35.25 | ▼ −8.80% | ▼ −9.32% | $40.48 (+4.72%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers